14.2
(0.0%)
Breakdown | 2023 | 2022 | 2021 |
---|---|---|---|
Operating Cash Flow | -583.12 Million | -665.81 Million | -442.97 Million |
Net Income | -692.79 Million | -626.78 Million | -684.62 Million |
Depreciation & Amortization | 35.2 Million | 22.76 Million | 14.56 Million |
Deferred income taxes | - | - | - |
Stock-based compensation | 26.38 Million | 33.16 Million | 16 Million |
Change in working capital | -38.45 Million | -147.6 Million | 217.35 Million |
Other non-cash items | 83.11 Million | 52.64 Million | -9.6 Million |
Investing Cash Flow | -27.18 Million | -37.6 Million | -10.16 Million |
Investments in PPE | -41.68 Million | -49.86 Million | -21.01 Million |
Acquisitions | - | - | - |
Investment purchases | - | - | - |
Sales/Maturities of investments | - | - | - |
Other Investing Activities | -6.88 Million | - | - |
Financing Cash Flow | 673 Million | 1.15 Billion | 4.52 Million |
Debt repayment | -13 Million | -30 Million | -10 Million |
Dividends payments | - | - | - |
Common Stock Repurchased | - | - | - |
Common Stock Issuance | 680.02 Million | 1.9 Million | - |
Other Financing Activities | -73.9 Million | 917.42 Million | - |
Accounts receivables | -5.78 Million | - | - |
Accounts payables | - | - | - |
Inventory | -11.16 Million | -7.14 Million | 12 Thousand |
Other working capital | -21.49 Million | - | - |
Cash at beginning of period | 553.66 Million | 86.98 Million | 535.59 Million |
Cash at end of period | 612.85 Million | 553.66 Million | 86.98 Million |
Capital Expenditure | -41.68 Million | -49.86 Million | -21.01 Million |
Effect of forex changes on cash | -3.49 Million | 10.95 Million | - |
Net cash flow / Change in cash | 59.19 Million | 466.68 Million | -448.61 Million |
Free Cash Flow | -624.81 Million | -715.68 Million | -463.99 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q2 | 2023 Q1 | 2022 FY |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -165.81 Million | -165.81 Million | -692.79 Million | -172.7 Million | -172.7 Million | -626.78 Million |
Depreciation & Amortization | - | - | 35.2 Million | - | - | 22.76 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | 959.5 Thousand | 959.5 Thousand | 26.38 Million | 2.93 Million | 2.93 Million | 33.16 Million |
Change in working capital | - | - | -38.45 Million | - | - | -147.6 Million |
Other non-cash items | 64.85 Million | 64.85 Million | 83.11 Million | -16.85 Million | -16.85 Million | 52.64 Million |
Investing Cash Flow | -464.5 Thousand | -464.5 Thousand | -27.18 Million | -7.96 Million | -7.96 Million | -37.6 Million |
Investments in PPE | -2.74 Million | -2.74 Million | -41.68 Million | -8.4 Million | -8.4 Million | -49.86 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 2.27 Million | 2.27 Million | - | 448.5 Thousand | 448.5 Thousand | - |
Financing Cash Flow | -20 Million | -20 Million | 673 Million | 117.35 Million | 117.35 Million | 1.15 Billion |
Debt repayment | - | - | -13 Million | - | - | -30 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | 680.02 Million | - | - | 1.9 Million |
Other Financing Activities | -20 Million | -20 Million | -73.9 Million | 117.35 Million | 117.35 Million | 917.42 Million |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | -11.16 Million | - | - | -7.14 Million |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | - | - | 553.66 Million | 475.19 Million | - | 86.98 Million |
Cash at end of period | -119.9 Million | -119.9 Million | 612.85 Million | 396.72 Million | -78.46 Million | 553.66 Million |
Capital Expenditure | -2.74 Million | -2.74 Million | -41.68 Million | -8.4 Million | -8.4 Million | -49.86 Million |
Effect of forex changes on cash | 569 Thousand | 569 Thousand | -3.49 Million | -1.23 Million | -1.23 Million | 10.95 Million |
Net cash flow / Change in cash | -119.9 Million | -119.9 Million | 59.19 Million | -78.46 Million | -78.46 Million | 466.68 Million |
Free Cash Flow | -102.74 Million | -102.74 Million | -624.81 Million | -195.03 Million | -195.03 Million | -715.68 Million |
HLBBF
3474
BIOWKS
DEXSF
4040
GTK